Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Other financing activities (2016 - 2025)

Historic Other financing activities for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $3.1 billion.

  • Fresenius Medical Care AG's Other financing activities rose 8707131.75% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year increase of 1273112.97%. This contributed to the annual value of $3.6 billion for FY2024, which is 170.87% down from last year.
  • Per Fresenius Medical Care AG's latest filing, its Other financing activities stood at $3.1 billion for Q3 2025, which was up 8707131.75% from $3.8 billion recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Other financing activities ranged from a high of $3.8 billion in Q2 2025 and a low of $1.4 million during Q1 2023
  • Moreover, its 5-year median value for Other financing activities was $19.6 million (2021), whereas its average is $1.3 billion.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Other financing activities tumbled by 8777.38% in 2023, and later soared by 8707131.75% in 2025.
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Other financing activities stood at $3.3 billion in 2021, then increased by 4.04% to $3.4 billion in 2022, then increased by 5.69% to $3.6 billion in 2023, then fell by 1.71% to $3.6 billion in 2024, then fell by 14.17% to $3.1 billion in 2025.
  • Its last three reported values are $3.1 billion in Q3 2025, $3.8 billion for Q2 2025, and $3.5 billion during Q1 2025.